Hemostasis, LLC

Keith Roberts is the CEO of Hemostasis, LLC. To contact Keith Roberts email at [email protected] or [email protected]. Or you may call +1.8888505087, +1.6514900386, (651) 402-7705, 6122198555 or 6516530030

The decision makers in Hemostasis, LLC are Chad Harris, John Burban, John Shanahan, etc. Click to Find Hemostasis, LLC decision makers emails.

NexStat Topical Hemostat Powder is an advanced hemostatic agent designed to control bleeding during surgical procedures and in emergency situations. It is intended for use under the supervision of a healthcare professional. The powder works by promoting rapid clot formation at the site of bleeding, making it particularly effective in ENT surgeries, cath lab procedures, and for controlling epistaxis (nosebleeds). Healthcare providers apply the powder directly to the bleeding site, where it interacts with blood components to enhance coagulation.

Hemostasis, LLC primarily supports the medical and surgical industries, focusing on specialties such as ENT (Ear, Nose, and Throat) surgery, interventional cardiology (Cath Lab), and trauma care. Their products are designed to address various hemostatic needs, including bone hemostasis, nasal dressings for epistaxis control, and other applications where rapid and effective bleeding control is critical.

Yes, Hemostasis, LLC products, including NexStat Topical Hemostat Powder, are designed to be safe for use in pediatric patients when administered by qualified healthcare professionals. However, it is essential for healthcare providers to evaluate each patient's specific needs and medical history before using any hemostatic agent. Proper training and adherence to guidelines are crucial to ensure safety and efficacy in pediatric applications.

NexStat Topical Hemostat Powder offers several advantages over traditional hemostatic agents. Its advanced formulation promotes faster clot formation, reduces the risk of rebleeding, and is easy to apply in various clinical settings. Unlike some traditional agents that may require prolonged application or additional steps, NexStat is designed for rapid deployment, making it particularly useful in emergency situations and surgical environments where time is critical.

Yes, NexStat Topical Hemostat Powder can be used in conjunction with other hemostatic products, depending on the clinical scenario and the healthcare provider's judgment. It is important for healthcare professionals to assess the specific needs of the patient and the nature of the bleeding when combining hemostatic agents. Coordination among the surgical team and adherence to established protocols will help ensure optimal outcomes.

Hemostasis, LLC products, including NexStat Topical Hemostat Powder, are typically available through medical supply distributors, hospitals, and surgical centers. Healthcare professionals interested in purchasing these products should contact their medical supply representative or visit the Hemostasis, LLC website for more information on authorized distributors and purchasing options.